| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
51,745 |
48,270 |
$1.58M |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
51,745 |
48,241 |
$1.57M |
| 87633 |
Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets |
277 |
274 |
$63K |
| 87471 |
|
1,559 |
980 |
$45K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
2,891 |
1,697 |
$8K |
| 83655 |
|
559 |
558 |
$6K |
| 86701 |
|
435 |
435 |
$3K |
| 87389 |
Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies |
164 |
151 |
$3K |
| 82633 |
|
54 |
54 |
$2K |
| 87636 |
Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B |
37 |
37 |
$1K |
| 86592 |
|
263 |
250 |
$926.00 |
| 87661 |
Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe |
15 |
15 |
$421.05 |